HarbourVest Partners LLC
- SEC CIK
- 0001201001
- Latest filing
- Aug 14, 2026
ALGS holding history
Aligos Therapeutics, Inc. in every 13F filed by HarbourVest Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALGS overviewAll 13F holders of ALGSFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −751−100.0% | Sold outConverted for a 1-for-25 split | Holders |
| Q2 2024 | 18,783 | $6.57K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 18,783 | $18.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 18,783 | $12.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 18,783 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 18,783 | $18.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 18,783 | $16.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 18,783 | $17.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 18,783 | $21.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 18,783 | $23.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 18,783 | $40.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 18,783 | $223.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 18,783 | $291.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 18,783 | $383.0K | <0.1% | +18,783 | New | Holders |